Monitoring and bloodwork requirements Any researcher considering this combination without comprehensive monitoring is making a serious mistake
Severe congestive heart failure (New York Heart Association Class III or IV): Semaglutide can affect heart function in susceptible patients
Results We included the 21 RCTs (n = 2900) with 21 effect sizes in this study
Serious Allergic Reactions: Swelling of the face, lips, tongue, or throat, difficulty breathing, severe rash, or dizziness
Actual experts talking about GLP-1s
semaglutide comparison after three years of head-to-head publications in one line, it would be this: at the pivotal dose and at 60-72 weeks, the average weight loss shows a clear progression from semaglutide to retatrutide